Newer contrast agents safe for childrenJune 08, 2007Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor. "A major, if not the main, risk associated with iodine-containing contrast agents is allergic types of reactions. Such reactions can be mild; for example, hives or severe such as difficulty breathing or even cardiopulmonary arrest," said Jonathan R. Dillman, MD, lead author of the study. "Over the past 20 years, we have changed the type of iodine-containing intravenous contrast agents used primarily for computed tomography (CT) and intravenous pyelogram (IVP) examinations in both adult and pediatric patients. The nonionic contrast media that we now use have been studied extensively in adults, but not as much in children. We performed our study because we wanted to find out what the exact risk of allergic reactions to these newer contrast agents was in children," said Dr. Dillman. The study evaluated 11,306 pediatric IV administrations of iodine-containing contrast agents over a seven year period. According to the study, acute allergic-like reactions were documented in 20 of the patients. Of these patients, 16 of the allergic-like reactions were categorized as mild, one as moderate, and three as severe. Six of the reacting patients had a history of allergic-like reactions, including two patients who had a history of reactions to iodinated contrast material. Five of the patients had a history of asthma. "While we have long assumed that newer nonionic contrast agents are safe, this study re-affirms their safety and better determines what the risks actually are in children," said Richard H. Cohan, MD, co-author of the study. "Our study confirms that doctors and parents alike can feel comfortable administering these agents to children," he said. The full results of this study appear in the June issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society. American Roentgen Ray Society |
|||||||||||||||||||||
| Related Contrast Agents Current Events and Contrast Agents News Articles Seeing previously invisible molecules for the first time A team of Harvard chemists led by X. Sunney Xie has developed a new microscopic technique for seeing, in color, molecules with undetectable fluorescence. Despite ongoing safety concerns, study finds adverse reactions from contrast agents rarely occur Iodinated and Gadolinium based contrast agents, frequently used during computed tomography (CT) and MRI scans to aid in the imaging process, are associated with a very low rate of adverse effects, according to a large cohort study published in the October issue of the American Journal of Roentgenology (AJR). Getting better visualization of joint cartilage through cationic CT contrast agents In its quest to find new strategies to treat osteoarthritis and other diseases, a Boston University-led research team has reported finding a new computer tomography contrast agent for visualizing the special distributions of glycosaminoglycans (GAGs) - the anionic sugars that account for the strength of joint cartilage. Twinkling nanostars cast new light into biomedical imaging Purdue University researchers have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging. Even at High Doses, Gadolinium-Based Contrast Agents Cannot by Themselves Cause Patients to Develop Nephrogenic Systemic Fibrosis Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems. Sodium bicarbonate reduces incidence of contrast-induced nephropathy A meta-analysis of 17 randomised controlled trials has shown that pre-procedural treatment with sodium bicarbonate based hydration is the optimal treatment strategy to prevent contrast-induced nephropathy (CIN). Fluorescent cancer cells to guide brain surgeons Gliomas are malignant brain tumors that arise from glial (supporting) cells of the brain. Gliomas are often resistant to chemotherapy. Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease An unlikely brew of seaweed and glow-in-the-dark biochemical agents may hold the key to the safe use of transplanted stem cells to treat patients with severe peripheral arterial disease (PAD), according to a team of veterinarians, basic scientists and interventional radiologists at Johns Hopkins. Novel technique changes lymph node biopsy, reduces radiation exposure in breast cancer patients Information obtained from a new application of photoacoustic tomography (PAT) is worth its weight in gold to breast cancer patients. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic. More Contrast Agents Current Events and Contrast Agents News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||